TY  - CHAP
M1  - Book, Section
TI  - Chapter 239. Lasers and Flashlamps in Dermatology
A1  - Landthaler, Michael
A1  - Bäumler, Wolfgang
A1  - Hohenleutner, Ulrich
A2  - Goldsmith, Lowell A.
A2  - Katz, Stephen I.
A2  - Gilchrest, Barbara A.
A2  - Paller, Amy S.
A2  - Leffell, David J.
A2  - Wolff, Klaus
Y1  - 2012
N1  - 
T2  - Fitzpatrick's Dermatology in General Medicine, 8e
AB  - |PrintLasers  and  Flashlamps  at  a  GlanceLasers  are  the  most  precise  and  selective  surgical  tools  in  existence.Nonscarring  treatment  of  vascular  lesions,  pigmented  lesions,  tattoos,  and  hair  follicles  relies  on  a  process  called  selective  photothermolysis.  For  each  of  the  aforementioned  broad  indications,  there  are  lesion  variants  that  are  highly  responsive  to  laser  therapy,  lesions  that  are  occasionally  responsive,  and  lesions  for  which  laser  treatment  is  contraindicated.Pulse  duration  strongly  influences  safety  and  efficacy,  and,  in  general,  should  be  approximately  equal  to  the  thermal  relaxation  (cooling)  time  of  specific  targets  in  a  given  patient.Port-wine  stains  are  congenital  neurovascular  lesions  best  treated  in  early  childhood  that  respond  well,  but  rarely  completely,  to  laser  treatment.Laser  treatment  is  useful  for  treatment  of  ulcerated  infant  hemangiomas.Fractional  resurfacing  is  a  technique  in  which  thousands  of  laser  microbeams  per  square  centimeter  are  used  to  stimulate  epidermal  and  dermal  remodeling.  It  is  a  less  invasive  treatment  for  photoaging  than  is  ablative  laser  resurfacing.Use  of  any  laser  or  flashlamp  (intense  pulsed  light)  for  hair  removal  poses  a  severe  risk  of  eye  injury  when  used  near  the  eye.  Other  risks  include  fires,  inhalation  of  the  vaporized  tissue  plume,  electrocution,  and  a  host  of  side  effects  such  as  stimulation  of  facial  hair  growth,  pigmentary  changes,  and  scarring.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/23
UR  - accessmedicine.mhmedical.com/content.aspx?aid=56104350
ER  -